Mirum Pharmaceuticals (MIRM) EBT Margin (2021 - 2026)
Mirum Pharmaceuticals (MIRM) recorded quarterly EBT Margin of 493.91% in Q1 2026, down 14721.61% quarter-over-quarter from 3.33% in Q4 2025, and down 48168.0% on a YoY basis from N/an in Q1 2025.
Mirum Pharmaceuticals (MIRM) EBT Margin (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' EBT Margin history runs 6 years deep, the most recent figure standing at 493.91% for Q1 2026.
- In Q1 2026, EBT Margin fell 48168.0% year-over-year to 493.91%; the TTM figure through Mar 2026 stood at 140.0% (down 11999.0% YoY), while the FY2025 annual figure was 4.11%, up 2169.0% from the prior year.
- EBT Margin was 493.91% for Q1 2026 at Mirum Pharmaceuticals, down from 3.33% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 1.99% in Q3 2025 to a low of 493.91% in Q1 2026.
- Historically, EBT Margin has averaged 106.16% across 5 years, with a median of 48.9% in 2023.
- Biggest YoY gain for EBT Margin was 75192 bps in 2022; the steepest drop was 196427 bps in 2022.
- A 5-year view of EBT Margin shows it stood at 130.05% in 2022, then soared by 61 bps to 50.94% in 2023, then jumped by 52 bps to 24.51% in 2024, then soared by 86 bps to 3.33% in 2025, then plunged by 14722 bps to 493.91% in 2026.
- The last three EBT Margin figures came in at 493.91% (Q1 2026), 3.33% (Q4 2025), and 1.99% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn | -493.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -493.91% |
| Dec 31, 2025 | -3.33% |
| Sep 30, 2025 | 1.99% |
| Jun 30, 2025 | -4.27% |
| Mar 31, 2025 | -12.23% |
| Dec 31, 2024 | -24.51% |
| Sep 30, 2024 | -15.37% |
| Jun 30, 2024 | -30.82% |
| Mar 31, 2024 | -35.62% |
| Dec 31, 2023 | -50.94% |
| Sep 30, 2023 | -48.90% |
| Jun 30, 2023 | -196.61% |
| Mar 31, 2023 | -94.72% |
| Dec 31, 2022 | -130.05% |
| Sep 30, 2022 | -190.06% |
| Jun 30, 2022 | -191.56% |
| Mar 31, 2022 | -283.86% |
| Dec 31, 2021 | 1,834.23% |
| Sep 30, 2021 | -941.98% |
| Jun 30, 2021 | -398.94% |